JP2006522100A5 - - Google Patents

Download PDF

Info

Publication number
JP2006522100A5
JP2006522100A5 JP2006506984A JP2006506984A JP2006522100A5 JP 2006522100 A5 JP2006522100 A5 JP 2006522100A5 JP 2006506984 A JP2006506984 A JP 2006506984A JP 2006506984 A JP2006506984 A JP 2006506984A JP 2006522100 A5 JP2006522100 A5 JP 2006522100A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
somatostatin
composition
peptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006506984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006522100A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/007143 external-priority patent/WO2004081031A2/en
Publication of JP2006522100A publication Critical patent/JP2006522100A/ja
Publication of JP2006522100A5 publication Critical patent/JP2006522100A5/ja
Pending legal-status Critical Current

Links

JP2006506984A 2003-03-10 2004-03-10 標的化ペプチドに対するチオール媒介性薬物結合 Pending JP2006522100A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45292803P 2003-03-10 2003-03-10
PCT/US2004/007143 WO2004081031A2 (en) 2003-03-10 2004-03-10 Thiol-mediated drug attachment to targeting peptides

Publications (2)

Publication Number Publication Date
JP2006522100A JP2006522100A (ja) 2006-09-28
JP2006522100A5 true JP2006522100A5 (OSRAM) 2007-04-26

Family

ID=32990704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506984A Pending JP2006522100A (ja) 2003-03-10 2004-03-10 標的化ペプチドに対するチオール媒介性薬物結合

Country Status (6)

Country Link
US (1) US20050118099A1 (OSRAM)
EP (1) EP1610805A2 (OSRAM)
JP (1) JP2006522100A (OSRAM)
AU (1) AU2004220104A1 (OSRAM)
CA (1) CA2518406A1 (OSRAM)
WO (1) WO2004081031A2 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100178245A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
WO2011133658A1 (en) 2010-04-22 2011-10-27 Boston Medical Center Corporation Compositions and methods for targeting and delivering therapeutics into cells
US9593052B2 (en) 2012-08-17 2017-03-14 The Curators Of The University Of Missouri Arsenic complexes for potential diagnostic applications
US20140051840A1 (en) * 2012-08-17 2014-02-20 The Curators Of The University Of Missouri Arsenic complexes for potential diagnostic applications
HK1213486A1 (zh) 2012-11-01 2016-07-08 Ipsen Pharma S.A.S. 促生长素抑制素类似物及其二聚体
TWI523863B (zh) * 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
WO2014127111A1 (en) * 2013-02-15 2014-08-21 The Scripps Research Institute Peptoids that bind specific antigens

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
US5877277A (en) * 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
US4925650A (en) * 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
JP3350701B2 (ja) * 1991-05-23 2002-11-25 メレルダウファーマスーティカルズ インコーポレイテッド ボンベシン類似体類
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5411943A (en) * 1992-02-25 1995-05-02 Biomeasure, Inc. Hepatoma treatment with somatostatin analogs
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
EP0599303A3 (en) * 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Peptide conjugate
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
US5708135A (en) * 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin
US5750499A (en) * 1995-10-18 1998-05-12 The Salk Institute For Biological Studies Receptor-selective somatostatin analogs
US6576746B2 (en) * 1998-10-13 2003-06-10 Immunomedics, Inc. Site-specific labeling of disulfide-containing targeting vectors
US6465613B1 (en) * 1998-11-19 2002-10-15 Tulane University Hydrophilic somatostatin analogs
US6309633B1 (en) * 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US6579967B1 (en) * 1999-12-14 2003-06-17 The Salk Institute For Biological Studies Receptor-selective somatostatin analogs
AU4267700A (en) * 2000-01-13 2001-07-19 Academia Sinica Application of somatostatin analogs to specific delivery of anti-tumor drugs into tumor cells

Similar Documents

Publication Publication Date Title
JP6486004B2 (ja) 疎水性修飾ペプチドおよび肝臓特異的標的化のためのその使用
AU2005279537C1 (en) GLP-1 and exendin related invention
CN101432025A (zh) 肽-肽酶抑制剂结合物及其使用方法
AU710923B2 (en) Radiolabeled peptides for diagnosis and therapy
AU2019232847A1 (en) Bi-terminal pegylated integrin-binding peptides and methods of use thereof
JP2008511557A5 (OSRAM)
KR20240160664A (ko) Igf-1r 모노클로날 항체 및 그의 용도
TW200944239A (en) Bombesin analog peptide antagonist conjugates
CN117603148A (zh) 双官能螯合物的药代动力学增强及其用途
CN120393061A (zh) 放射性免疫缀合物与dna损伤和修复抑制剂组合疗法
CN118451091A (zh) 用于靶向细胞表面受体的可裂解放射性配体及其用途
JP2011521897A5 (OSRAM)
JP2006265245A5 (OSRAM)
SA520411366B1 (ar) نظير ببتيد أوكسينتو موديولين معالج بأسيل
Marsouvanidis et al. Gastrin releasing peptide receptor-directed radioligands based on a bombesin antagonist: synthesis, 111In-labeling, and preclinical profile
JP2010539112A (ja) 抗腫瘍薬のための分類マーカーとしてのｅｄ‐ｂフィブロネクチン
TW202340226A (zh) 碳酸酐酶ix配位體
Maina et al. [99mTc] Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results
JP2009529915A5 (OSRAM)
JP2007506713A (ja) 例えば、抗血管新生活性を有するペプチドおよび治療におけるその適用
KR101523686B1 (ko) 췌도 이미징용 분자 프로브 및 그 사용
CN109316609B (zh) 选择患者的方法
JP2008539795A5 (OSRAM)
Giblin et al. In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers
CN118591549A (zh) 碳酸酐酶ix配位体